Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA.

Crystal structure Farnesoid X receptor Heterodimer Inverted repeat DNA Retinoid X receptor

Journal

Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369

Informations de publication

Date de publication:
2023
Historique:
received: 30 03 2023
revised: 22 05 2023
accepted: 23 05 2023
medline: 8 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: epublish

Résumé

Farnesoid X receptor (FXR) is a ligand-activated transcription factor known as bile acid receptor (BAR). FXR plays critical roles in various biological processes, including metabolism, immune inflammation, liver regeneration and liver carcinogenesis. FXR forms a heterodimer with the retinoid X receptor (RXR) and binds to diverse FXR response elements (FXREs) to exert its various biological functions. However, the mechanism by which the FXR/RXR heterodimer binds the DNA elements remains unclear. In this study, we aimed to use structural, biochemical and bioinformatics analyses to study the mechanism of FXR binding to the typical FXRE, such as the IR1 site, and the heterodimer interactions in the FXR-DBD/RXR-DBD complex. Further biochemical assays showed that RAR, THR and NR4A2 do not form heterodimers with RXR when bound to the IR1 sites, which indicates that IR1 may be a unique binding site for the FXR/RXR heterodimer. Our studies may provide a further understanding of the dimerization specificity of nuclear receptors.

Identifiants

pubmed: 37287811
doi: 10.1016/j.csbj.2023.05.026
pii: S2001-0370(23)00208-8
pmc: PMC10242635
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3149-3157

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Nature. 2023 Mar;615(7950):134-142
pubmed: 36470304
Nucleic Acids Res. 2021 Apr 6;49(6):3573-3583
pubmed: 33577686
Cell Metab. 2021 Aug 3;33(8):1671-1684.e4
pubmed: 34270928
J Biol Chem. 2018 Aug 10;293(32):12535-12541
pubmed: 29934308
Nat Struct Mol Biol. 2014 Mar;21(3):277-81
pubmed: 24561505
Nat Commun. 2016 Feb 18;7:10713
pubmed: 26888176
Nat Commun. 2019 Jun 7;10(1):2514
pubmed: 31175293
Chem Rev. 2014 Jan 8;114(1):233-54
pubmed: 24308533
Comput Struct Biotechnol J. 2021 Apr 20;19:2148-2159
pubmed: 33995909
Curr Opin Struct Biol. 2001 Feb;11(1):33-8
pubmed: 11179889
Nature. 2008 Nov 20;456(7220):350-6
pubmed: 19043829
J Hepatol. 2016 May;64(5):1158-1166
pubmed: 26812075
Am J Physiol Gastrointest Liver Physiol. 2002 Jun;282(6):G926-31
pubmed: 12016116
Nat Commun. 2014 Jun 19;5:4139
pubmed: 24942373
Trends Biochem Sci. 2015 Jan;40(1):16-24
pubmed: 25435400
J Clin Invest. 2002 Apr;109(7):961-71
pubmed: 11927623
J Biol Chem. 2018 Nov 23;293(47):18180-18191
pubmed: 30275017
EMBO J. 2003 Nov 3;22(21):5827-40
pubmed: 14592980
J Mol Endocrinol. 2022 Oct 11;69(4):T25-T36
pubmed: 36069789
J Mol Biol. 2000 Feb 18;296(2):509-20
pubmed: 10669605
Acta Pharm Sin B. 2015 Mar;5(2):135-44
pubmed: 26579439
Nature. 1991 Aug 8;352(6335):497-505
pubmed: 1865905
BMC Bioinformatics. 2012 Mar 28;13 Suppl 4:S2
pubmed: 22536966
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Endocrinology. 2016 Nov;157(11):4212-4221
pubmed: 27704949
Gastroenterology. 2020 Nov;159(5):1853-1865.e10
pubmed: 32712104
Nature. 1995 May 18;375(6528):203-11
pubmed: 7746322
J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):215-9
pubmed: 15225774
Biochemistry. 2001 Oct 30;40(43):12833-43
pubmed: 11669620
Nucleic Acids Res. 2020 Sep 25;48(17):9969-9985
pubmed: 32974652
Nucleic Acids Res. 2019 Apr 23;47(7):3752-3764
pubmed: 30722065
Bioinformatics. 2016 May 15;32(10):1555-6
pubmed: 26794315
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Acta Pharmacol Sin. 2015 Jan;36(1):37-43
pubmed: 25500874
Trends Biochem Sci. 2001 Jun;26(6):384-90
pubmed: 11406412
BMC Bioinformatics. 2010 May 11;11:237
pubmed: 20459804
BMC Genomics. 2013 Aug 28;14:575
pubmed: 23981290
Cell Res. 2008 Nov;18(11):1087-95
pubmed: 18825165
J Med Chem. 2005 May 5;48(9):3251-9
pubmed: 15857131
Mol Endocrinol. 2004 Sep;18(9):2166-84
pubmed: 15192079
Nat Commun. 2017 Oct 11;8(1):868
pubmed: 29021580
Mol Cell Endocrinol. 2022 May 15;548:111618
pubmed: 35283218
Mol Cell. 1998 May;1(6):849-61
pubmed: 9660968
Hepatology. 2010 Apr;51(4):1410-9
pubmed: 20091679
Acta Crystallogr D Struct Biol. 2022 Jul 1;78(Pt 7):890-902
pubmed: 35775988
Expert Rev Gastroenterol Hepatol. 2020 May;14(5):311-321
pubmed: 32241197
Cell. 2014 Mar 27;157(1):255-66
pubmed: 24679540
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Methods Mol Biol. 2016;1482:259-77
pubmed: 27557773
Drugs. 2016 Aug;76(12):1221-6
pubmed: 27406083
J Mol Endocrinol. 2013 Nov 07;51(3):T1-T21
pubmed: 24103914
EMBO J. 2000 Mar 1;19(5):1045-54
pubmed: 10698945
Mol Cell Endocrinol. 2012 Jan 30;348(2):411-7
pubmed: 21801809
Protein Sci. 1995 Nov;4(11):2411-23
pubmed: 8563639
Nature. 2013 Mar 21;495(7441):394-8
pubmed: 23485969
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
J Biol Chem. 2019 Dec 20;294(51):19795-19803
pubmed: 31723028

Auteurs

Longying Jiang (L)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Xueke Liu (X)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Xujun Liang (X)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Shuyan Dai (S)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Hudie Wei (H)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Ming Guo (M)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Zhuchu Chen (Z)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Desheng Xiao (D)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Yongheng Chen (Y)

Department of Pathology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Classifications MeSH